Instinct Bio partners with Indonesia’s Parva Candela to expand cosmetics businessPUBT·Aug 10 at 06:05 AMBIOT+2.31%
U.S. Stock Market Midday Update: Down 57.89% after securing $150 million in financing, concerns arise over Instinct Bio's prospectsPrice Alert·Jul 29 at 08:43 AMBIOT+2.31%
Pre-market hot trades in US stocks: Marwynn up 54.27% in pre-market; Instinct Bio Technical down 21.80% in pre-marketPrice Alert·Jul 29 at 03:18 AMMWYN-0.95%BIOT+2.31%
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets | BIOT Stock NewsStockTitan·Jul 29 at 01:28 AMBIOT+2.31%
Instinct Bio Stock Slides After Hours: Here's What is Going on With BIOTbenzinga_article·Jul 29 at 12:37 AMBIOT+2.31%
U.S. stock market midday update: Instinct Bio down 35.40% on increased volume, no major negative news but unusual capital movement observedPrice Alert·Jul 28 at 08:58 AMBIOT+2.31%
Pre-market hot trades in US stocks: Instinct Bio Technical pre-market down 15.25%; AiRWA pre-market down 14.33%Price Alert·Jul 28 at 03:23 AMBIOT+2.31%YYAI-9.66%
Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth | ACQC Stock NewsStockTitan·Jul 28 at 01:01 AMBIOT+2.31%
U.S. stock market midday update: Instinct Bio down 63.61%, no major negative news, capital movement draws attentionPrice Alert·Jul 27 at 08:58 AMBIOT+2.31%
